$NMEX
NORTHERN MINERALS & EXPLORATION LTD.

2023 Q4 Form 10-Q Financial Statement

#000143774923034166 Filed on December 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $58.80K $51.65K
YoY Change 13.84% 0.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $58.82K $51.65K
YoY Change 13.88% 0.3%
Operating Profit -$58.82K -$51.65K
YoY Change 13.88% 0.3%
Interest Expense $2.870K $1.585K
YoY Change 81.07% -20.11%
% of Operating Profit
Other Income/Expense, Net -$2.870K -$104.00
YoY Change 2659.62%
Pretax Income -$61.69K -$51.76K
YoY Change 19.18% -3.22%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$61.69K -$51.76K
YoY Change 19.19% 81.55%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$627.30
COMMON SHARES
Basic Shares Outstanding 89.06M 87.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.100K $2.790K
YoY Change -24.73% -85.17%
Cash & Equivalents $2.105K $2.791K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.105K $2.791K
YoY Change -24.58% -85.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.105K $2.791K
Total Long-Term Assets $0.00 $0.00
Total Assets $2.105K $2.791K
YoY Change -24.58% -85.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $92.20K $69.51K
YoY Change 32.64% 9.85%
Accrued Expenses $28.75K $307.0K
YoY Change -90.64% -10.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $79.00K
YoY Change -100.0% -32.6%
Long-Term Debt Due $86.00K $0.00
YoY Change
Total Short-Term Liabilities $206.9K $489.9K
YoY Change -57.77% -11.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $85.00K
YoY Change
Total Long-Term Liabilities $85.00K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $206.9K $489.9K
Total Long-Term Liabilities $85.00K $0.00
Total Liabilities $291.9K $489.9K
YoY Change -40.42% -11.27%
SHAREHOLDERS EQUITY
Retained Earnings -$3.430M -$3.443M
YoY Change -0.39% 3.58%
Common Stock $89.06K $82.51K
YoY Change 7.94% 8.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$289.8K -$487.1K
YoY Change
Total Liabilities & Shareholders Equity $2.105K $2.791K
YoY Change -24.58% -85.17%

Cashflow Statement

Concept 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$61.69K -$51.76K
YoY Change 19.19% 81.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$37.80K -$23.02K
YoY Change 64.17% -54.1%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $33.00K $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$37.80K -$23.02K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $33.00K $0.00
Net Change In Cash -$4.795K -$23.02K
YoY Change -79.17% -229.0%
FREE CASH FLOW
Cash From Operating Activities -$37.80K -$23.02K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89059357
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89059357
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001415744
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93809357
CY2023Q4 nmex Related Party Consulting Expenses
RelatedPartyConsultingExpenses
18000 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
18100 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16120 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10552 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
58820 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-58820 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
2870 usd
CY2023Q4 us-gaap Other Income
OtherIncome
0 usd
CY2022Q4 us-gaap Other Income
OtherIncome
1481 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-104 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51756 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51756 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82509357
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-435364 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-487120 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-261116 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-61690 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-289806 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-61690 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1595 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1585 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37795 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23022 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4795 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23022 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6900 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25813 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2105 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2791 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
1275 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Use of estimates</span></i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2023Q4 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; "><i>Reclassifications</i></span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the financial statements for the three months ended October 31, 2023.</p>
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3429533 usd
CY2020Q2 us-gaap Unsecured Debt
UnsecuredDebt
14000 usd
CY2021Q1 us-gaap Unsecured Debt
UnsecuredDebt
5000 usd
CY2022 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
15000 usd
CY2023Q3 us-gaap Unsecured Debt
UnsecuredDebt
7000 usd
CY2023Q4 us-gaap Unsecured Debt
UnsecuredDebt
11000 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8000 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
8000 usd
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1000000
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd

Files In Submission

Name View Source Status
0001437749-23-034166-index-headers.html Edgar Link pending
0001437749-23-034166-index.html Edgar Link pending
0001437749-23-034166.txt Edgar Link pending
0001437749-23-034166-xbrl.zip Edgar Link pending
ex_602186.htm Edgar Link pending
ex_602187.htm Edgar Link pending
ex_602188.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nmex-20231031.xsd Edgar Link pending
nmex20231031_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nmex-20231031_pre.xml Edgar Link unprocessable
nmex-20231031_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nmex-20231031_lab.xml Edgar Link unprocessable
nmex-20231031_cal.xml Edgar Link unprocessable
nmex20231031_10q_htm.xml Edgar Link completed